NCT06194084

Brief Summary

This clinical study investigates the impacts of daily durian consumption on gut microbiota, gut microbial metabolites, and host metabolome in healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 8, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2025

Completed
Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

2.6 years

First QC Date

November 23, 2023

Last Update Submit

September 25, 2025

Conditions

Keywords

Precision NutritionDurianGut MicrobiomeMetabolome

Outcome Measures

Primary Outcomes (14)

  • Fasted Blood Glucose

    Changes in Fasted Blood Glucose (mg/dL), before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • HbA1C

    Changes in HbA1C (%) before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Total Cholesterol

    Changes in Total Cholesterol (mg/dL) before \& after Durian Intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • HDL Cholesterol

    Changes in HDL Cholesterol (mg/dL) before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • LDL Cholesterol

    Changes in LDL Cholesterol (mg/dL) before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Cholesterol/HDL Ratio

    Changes in Cholesterol/HDL ratio before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Triglycerides

    Changes in Triglycerides (mg/dL) before \& after Durian intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Carbohydrates

    Food record for carbohydrate intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Protein

    Food record for protein intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Fats

    Food record for fat intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Dietary Fibre

    Food record for dietary fibre intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Cholesterol

    Food record for cholesterol intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Sodium

    Food record for sodium intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Sugar

    Food record for sugar intake.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Secondary Outcomes (2)

  • Changes in gut microbiome composition before and after Intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  • Changes in metabolomes before and after Intervention.

    Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Other Outcomes (1)

  • Plasma Samples obtained from 50 healthy participants form different multi-ethnicity (Malays, Chinese and Indians) will be genotyped using a custom single nucleotide polymorphism (SNP) genotyping array (Illumina OncoArray-500K Bead Chip).

    Baseline.

Study Arms (1)

Intervention - durian pulp.

EXPERIMENTAL

Two-sequence of doses (100 g and 200 g) of durian pulp.

Other: Two-sequence of durian pulp doses (100 g and 200 g)

Interventions

Participants first go through an initial washout maintaining a low-fiber diet for 14 days. After washout, participants will be instructed to consume 100 grams of durian pulp every day following their breakfast or dinner for 1 week. Participants will then continue to consume 200 grams of durian pulp every day during the 2nd week of intervention and then will go through another washout for 2 weeks.

Intervention - durian pulp.

Eligibility Criteria

Age21 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male and/or female subjects between the ages of 21 and 60 years, inclusive
  • Willing and able to provide written informed consent
  • Must be in generally good health with clinically insignificant screening results (Fasting plasma glucose level \& Lipid profile), as determined by the Investigator
  • Agrees to consume durian for 2 weeks
  • Agrees to maintain a low-fiber diet during the intervention
  • Have not received any antibiotics therapy, consumed prebiotics, probiotics, symbiotic /vitamin supplement, and/or TCM for at least 1 month before the start of the study
  • Have not received any medical treatment that would impact on intestinal microbiota at least 6 months before the start of the study or during the study
  • Recent COVID-19 vaccination received or infection with COVID-19 at least 2 months ago

You may not qualify if:

  • Known or suspected sensitivity/allergy to durian
  • Multiple food/drug allergies
  • Smoker
  • History or presence of current metabolic conditions and gastrointestinal diseases
  • Diagnosed with Inflammatory Bowel Disease (IBD) or significant liver enzyme abnormality
  • Presence of current haemorrhoids or piles causing rectal bleeding when passing stool
  • Pregnant, breastfeeding or intending to conceive during study period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cancer Centre, Singapore

Singapore, 168583, Singapore

Location

Study Officials

  • Jason YS CHAN, MD, PhD

    National Cancer Centre, Singapore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2023

First Posted

January 8, 2024

Study Start

February 1, 2023

Primary Completion

August 29, 2025

Study Completion

August 29, 2025

Last Updated

October 1, 2025

Record last verified: 2025-09

Locations